#Canada #Israel #Calgary #Decibel Cannabis #General Admission

Decibel Cannabis Company Expands into Israel

Decibel Cannabis Company Inc. has recently announced a significant expansion move, marking its entry into the Israeli cannabis market. This initiative comes through a strategic supply agreement and trademark license with Keren Tirk Ltd., a partnership that positions Decibel to offer its well-regarded General Admission brand directly to medical cannabis patients in Israel.

With a track record of success, General Admission has established itself as a top cannabis brand in Canada, known for its commitment to quality, accessibility, and innovation. Decibel's Chief Revenue Officer, Adam Coates, emphasized the excitement surrounding this expansion. He stated, "We're thrilled to leverage the goodwill we've cultivated in the Canadian market to elevate General Admission into a globally recognized brand. As we forge into new territories, our dedication to delivering exceptional products and value continues to guide us."

Key Details and Future Prospects

The initial shipment of General Admission-branded products is projected for the second quarter of 2025. This timely entry into the Israeli market comes with a robust plan to position General Admission products within the mainstream cannabis segment, making premium cannabis more accessible to a broader audience.

Alongside existing Qwest-branded products, the introduction of General Admission presents Decibel with an opportunity to diversify its offerings and tap into the larger global market segment effectively. Historically, Decibel has concentrated on premium-priced products; however, this strategic maneuver signifies a willingness to embrace larger-volume opportunities in the mainstream product realm.

About Decibel Cannabis Company

Decibel is a consumer-centric cannabis company with a mission to bring delightful, innovative products to the market. With a portfolio that includes well-known brands like General Admission, Qwest, and Vox, Decibel's products are accessible across Canada and are now set to venture into international markets. Following a recent acquisition in late 2024, Decibel has also added an EU-GMP certified facility to its operations, ensuring compliance with stringent international standards and further bolstering its global growth aspirations.

With three cultivation facilities and a dedicated processing and manufacturing center, Decibel is positioned as a prominent leader in delivering high-quality cannabis products worldwide. The company is committed to its mission of robust innovation and product excellence, traits that will undoubtedly serve it well in the evolving international cannabis landscape.

In supporting its efforts, Decibel is also aware of the nature of forward-looking statements and acknowledges the inherent risks and uncertainties involved in market expansion. As the company strives to delight its customers with quality and innovation, it remains a notable player in the ever-changing cannabis space, dedicated to maintaining high standards as it explores new frontiers.

Conclusion

Decibel's strategic decision to broaden its canvas into the Israeli market sets a promising precedent for the future. With the strength of the General Admission brand behind it, Decibel is not only enhancing its market share but also paving the way for a more extensive global reach. This venture will not just serve the medical cannabis patients in Israel but also reinforce Decibel's standing as a leading brand in the global cannabis industry.